PMA device
Simplera Sync Sensor, Guardian 4 Sensor
Medtronic Minimed, Inc. · Sensor, Glucose, Invasive, Component Of Automated Insulin Delivery System (SFI, Class III) · First FDA decision Aug 6, 2025, newest Aug 6, 2025Diabetes
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
1
Naming "Simplera Sync"
MAUDE reports
1,356
Brand "Simplera Sync", since 2015
PubMed studies
7
Mentioning "Simplera Sync"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
P250012 · Decided Aug 6, 2025 · 110 days after receipt
Device type: Sensor, Glucose, Invasive, Component of automated insulin delivery system (SFI) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Simplera Sync", any status and sponsor, newest update first.
- GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With DiabetesPivotal-lookingActive, not recruiting
Medtronic MiniMed, Inc.Public (MDT)
NCT07228117 · 389 participants · Start Feb 2, 2026 · Primary completion Jan 2027
Device: MiniMed™ NMX8-AID System with DS5™/Simplera Sync™ · For: Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
Sites: Little Rock, Arkansas; Escondido, California; Goleta, California · 33 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Simplera Sync", and for the whole product code for context.
This brand
1,356 reports: 1,272 malfunction, 84 injury, 0 death
Whole product code SFI
5,905 reports: 5,762 malfunction, 143 injury, 0 death
Newest reports for this brand
- SENSOR MMT-5120B SIMPLERA SYNC 1PK USMalfunction
Medtronic Puerto Rico Operations Co.
2032227-2026-264296 · Received Oct 30, 2026 · Event dated Oct 17, 2026
Device type: Sensor, Glucose, Invasive, Component Of Automated Insulin Delivery System (SFI)
Device problem as coded: Wireless Communication Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- SENSOR MMT-5120B SIMPLERA SYNC 1PK USMalfunction
2032227-2026-264301 · Received Oct 30, 2026 · Event dated Oct 18, 2026
Device type: Sensor, Glucose, Invasive, Component Of Automated Insulin Delivery System (SFI)
Device problem as coded: Incorrect, Inadequate or Imprecise Result or Readings; Calibration Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Medtronic Puerto Rico Operations Co.
2032227-2026-264857 · Received Oct 30, 2026 · Event dated Oct 10, 2026
Device type: Sensor, Glucose, Invasive, Component Of Automated Insulin Delivery System (SFI)
Device problem as coded: Incorrect, Inadequate or Imprecise Result or Readings
Patient problem as coded: Hyperglycemia
- SENSOR MMT-5120A SIMPLERA SYNC 5PK USMalfunction
2032227-2026-263619 · Received Oct 29, 2026 · Event dated Oct 19, 2026
Device type: Sensor, Glucose, Invasive, Component Of Automated Insulin Delivery System (SFI)
Device problem as coded: Wireless Communication Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- SENSOR MMT-5120A SIMPLERA SYNC 5PK USMalfunction
2032227-2026-263848 · Received Oct 29, 2026 · Event dated Oct 1, 2026
Device type: Sensor, Glucose, Invasive, Component Of Automated Insulin Delivery System (SFI)
Device problem as coded: Wireless Communication Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Simplera Sync"[tiab]. The summary above synthesizes these.
- Safety and Glycemic Outcomes of the MiniMed 780G System with a Disposable All-in-One Sensor.
Nally LM, Sherr JL, Garg SK, et al. · Diabetes Technol Ther · 2026Multicenter Study, Research Support, Non-U.S. Gov't
- Impact of Simplera Syncࡊ sensors and Extendedࡊ Wear Infusion Sets on glycaemia and system performance of the MiniMedࡊ 780G system in children and young adults with previously high HbA1c.
Michaels VR, Boucsein A, Zhou Y, et al. · Diabet Med · 2025Randomized Controlled Trial
- Glycemic Concordance of Simplera Syncࡊ and Instinctࡊ Sensors in MiniMedࡊ 780G System Users: A Randomized Crossover Feasibility Study.
Laron-Hirsh M, Barel S, Roy A, et al. · Diabetes Technol Ther · 2026Equivalence Trial, Randomized Controlled Trial
- Enhancing user experience with an automated insulin delivery system by upgrading to a next generation sensor.
Beato-Víbora PI, Gil-Poch E, Arroyo-Díez FJ · Diab Vasc Dis Res · 2026
- Consistent efficacy and safety of automated insulin delivery in children aged 2-6 years: results from the LENNY trial continuation phase.
Dovc K, Tuomaala A, Kuusela S, et al. · Diabetes Res Clin Pract · 2025Randomized Controlled Trial, Equivalence Trial
- Experiences with Simplera syncࡊ all-in-one sensors and extended wear infusion sets in adolescents and young adults using the MiniMedࡊ 780G: A qualitative study.
Michaels VR, Crocket HR, Boucsein A, et al. · Diabet Med · 2026
- All-in-one sensor design with overlapping sensor transition reduces automode interruptions and improves patient-reported outcomes in adolescents with type 1 diabetes: real-world evidence from simplera sync integration.
Marigliano M, Scaramuzza A, Bonfanti R, et al. · Diabetes Res Clin Pract · 2026
Other devices of this type
Also filed under product code SFI.
- Guardian 4 SensorMedtronic Minimed, Inc. · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.